Citation: Hg. Meerpohl, COMBINATION PACLITAXEL (TAXOL(R))-CARBOPLATIN AS FIRST-LINE THERAPY FOR ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 7, 1997, pp. 18-22
Authors:
MROSS K
HARING B
HAUNS B
MAIERLENZ H
BAUKNECHT T
MEERPOHL HG
DIERGARTEN K
UNGER C
Citation: K. Mross et al., CLINICAL AND PHARMACOKINETIC PHASE-I STUDY WITH TAXOL(R) GIVEN AS SHORT 1-HOUR INTRAVENOUS-INFUSION, European journal of cancer, 33, 1997, pp. 1135-1135
Authors:
DUBOIS A
LUCK HJ
BUSER K
MEERPOHL HG
SESSA C
KLAASSEN U
MEDEN H
BOCHTLER H
DIERGARTEN K
Citation: A. Dubois et al., EXTENDED PHASE-II STUDY OF PACLITAXEL AS A 3-H INFUSION IN PATIENTS WITH OVARIAN-CANCER PREVIOUSLY TREATED WITH PLATINUM, European journal of cancer, 33(3), 1997, pp. 379-384
Citation: Hg. Meerpohl et W. Jonat, RELATED SYMPOSIA - CHEMOTHERAPY OF GYNECO LOGICAL CANCER WITH TAXOL -CHEMOTHERAPY OF GYNECOLOGICAL CANCER WITH PACLITAXEL (TAXOL), Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 372-377
Authors:
DUBOIS A
LUCK HJ
BAUKNECHT T
MOBUS V
BOCHTLER H
DIERGARTEN K
MEERPOHL HG
Citation: A. Dubois et al., PHASE-I PHASE-II STUDY OF THE COMBINATION OF CARBOPLATIN AND PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER/, Annals of oncology, 8(4), 1997, pp. 355-361
Authors:
MAIERLENZ H
HAUNS B
HAERING B
KOETTING J
MROSS K
UNGER C
BAUKNECHT T
DUBOIS A
MEERPOHL HG
HOLLAENDER N
DIERGARTEN K
Citation: H. Maierlenz et al., PHASE-I STUDY OF PACLITAXEL ADMINISTERED AS A 1-HOUR IN FUSION - TOXICITY AND PHARMACOKINETICS, Seminars in oncology, 24(6), 1997, pp. 16-19
Authors:
LUCK HJ
THOMSSEN C
DUBOIS A
LISBOA BW
UNTCH M
KUHNLE H
JANICKE F
MEERPOHL HG
LINDNER C
KCNECNY G
HECKER D
DIERGARTEN K
Citation: Hj. Luck et al., PRELIMINARY-RESULTS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 24(1), 1997, pp. 13-16
Authors:
MEERPOHL HG
DUBOIS A
LUCK HJ
KUHNLE H
MOBUS V
KREIENBERG R
BAUKNECHT T
KOCHLI O
BOCHTLER H
DIERGARTEN K
Citation: Hg. Meerpohl et al., PACLITAXEL COMBINED WITH CARBOPLATIN IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - A PHASE-I TRIAL, Seminars in oncology, 24(1), 1997, pp. 17-22
Authors:
MEERPOHL HG
SAUERBREI W
KUHNLE H
SCHUMACHER M
PFLEIDERER A
Citation: Hg. Meerpohl et al., RANDOMIZED STUDY COMPARING CARBOPLATIN CYCLOPHOSPHAMIDE AND CISPLATIN/CYCLOPHOSPHAMIDE AS FIRST-LINE TREATMENT IN PATIENTS WITH STAGE III/IV EPITHELIAL OVARIAN-CANCER AND SMALL-VOLUME DISEASE/, Gynecologic oncology, 66(1), 1997, pp. 75-84
Authors:
DALL P
MEERPOHL HG
HENNE K
DUBOIS A
ACHTERRATH W
FROMMHOLD H
PFLEIDERER A
Citation: P. Dall et al., COMBINED RADIOCHEMOTHERAPY IN ADVANCED CERVICAL-CANCER - A PHASE-II TRIAL WITH WEEKLY APPLIED CARBOPLATIN, 5-FLUOROURACIL AND FOLINIC ACID, International journal of gynecological cancer, 6(1), 1996, pp. 20-26
Authors:
HEBART H
ERLEY C
KASKAS B
MAYER R
KONIG M
EINSELE H
BOKEMEYER C
MEERPOHL HG
FEINE U
KANZ L
Citation: H. Hebart et al., POSITRON EMISSION TOMOGRAPHY HELPS TO DIAGNOSE TUMOR EMBOLI AND RESIDUAL DISEASE IN CHORIOCARCINOMA, Annals of oncology, 7(4), 1996, pp. 416-418
Authors:
WEHRENS B
DUBOIS A
ROESSEL U
FUTTERER K
GOCKEL G
SCHNEIDER HM
MEERPOHL HG
Citation: B. Wehrens et al., URACHAL CARCINOMA AS 2ND PRIMARY NEOPLASM AFTER RADIOTHERAPY OF ENDOMETRIAL CARCINOMA, Tumordiagnostik & Therapie, 17(1), 1996, pp. 22-24
Authors:
LUCK HJ
THOMSSEN C
DUBOIS A
LISBOA BW
UNTCH M
KUHNLE H
KONECNY G
JANICKE F
MEERPOHL HG
LINDNER C
HECKER D
DIERGARTEN K
Citation: Hj. Luck et al., INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 33-36
Citation: A. Dubois et al., PACLITAXEL-INDUCED RECALL SOFT-TISSUE ULCERATIONS OCCURRING AT THE SITE OF PREVIOUS SUBCUTANEOUS ADMINISTRATION OF PACLITAXEL IN LOW-DOSES, Gynecologic oncology, 60(1), 1996, pp. 94-96
Citation: A. Mollenkopf et al., SEQUENTIAL COURSE AND PROSPECTIVE MANAGEM ENT IN IFOSFAMIDE-INDUCED MULTIORGAN TOXICITY, Geburtshilfe und Frauenheilkunde, 56(10), 1996, pp. 525-528
Authors:
DUBOIS A
VACH W
CRAMERGIRAUD U
THOMSSEN C
GLAUBITZ M
FIOLA M
AUGENER W
BARTSCH W
BERGMANN F
BIERBAUM W
KRAPP J
BONING L
BONGARTZ U
BRUNTSCH U
VONBULTZINGSLOWEN F
DIETL J
FUGER T
FULLE HH
GATZEMEIER U
GROPP C
HARTLAPP H
HERSCHLEIN HJ
HOLTKAMP W
HURST U
JANICKE F
KAUKEL E
KLEEBERG U
ENGEL E
KRAFFT W
KUHNLE H
LINDEMANN H
MARSCHNER N
MEERPOHL HG
NIEDERLE N
OSIEKA R
PLANKER M
RIESS H
SCHMIDT M
SCHMOLL HJ
SCHUNEMANN H
WEINGARTJESSE B
WEITZEL H
WESTERHAUSEN M
WINKELMANN M
Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651
Authors:
DUBOIS A
KRIESINGERSCHROEDER H
MEERPOHL HG
Citation: A. Dubois et al., THE ROLE OF SEROTONIN AS A MEDIATOR OF EMESIS INDUCED BY DIFFERENT STIMULI, Supportive care in cancer, 3(5), 1995, pp. 285-290
Authors:
MEERPOHL HG
DUBOIS A
KUHNLE H
LUCK HJ
KREIENBERG R
MOBUS V
BAUKNECHT T
KOCHLI O
BOCHTLER H
DIERGARTEN K
HEUSER A
Citation: Hg. Meerpohl et al., PACLITAXEL COMBINED WITH CARBOPLATIN IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER, Seminars in oncology, 22(6), 1995, pp. 7-12